Treatment of protozoan infections

Dermatologic Therapy

Volumn 17, Issue 6, 2004, Pages 513-516

  Sra, Karan K ^a   Sracic, Julie ^b   Tyring, Stephen K ^c  

^a CENTER FOR CLINICAL STUDIES   (United States)

^b St Joseph's Medical Center Houston   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Amebiasis; Leishmaniasis; Protozoa; Toxoplasmosis; Trypanosomiasis

Indexed keywords

ALLOPURINOL; AMPHOTERICIN B; ANTIMALARIAL AGENT; DILOXANIDE; EFLORNITHINE; EMETINE; FLUCONAZOLE; IMIQUIMOD; KETOCONAZOLE; MEGLUMINE ANTIMONATE; MELARSOPROL; METRONIDAZOLE; MILTEFOSINE; NIFURTIMOX; PAROMOMYCIN; PENTAMIDINE; PENTAMIDINE ISETHIONATE; PYRIMETHAMINE; STIBOGLUCONATE SODIUM; SULFADIAZINE; SURAMIN; TINIDAZOLE; TOLAZOLINE;

AFRICAN TRYPANOSOMIASIS; AMEBIASIS; AMINOTRANSFERASE BLOOD LEVEL; ANOREXIA; ARTHRALGIA; CARDIOTOXICITY; CHAGAS DISEASE; CLINICAL FEATURE; CRYOTHERAPY; ENTAMOEBA HISTOLYTICA; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; LEISHMANIA MAJOR; LEISHMANIA MEXICANA; LEISHMANIA TROPICA; LEISHMANIASIS; LEUKOPENIA; LIFE CYCLE; MALAISE; NONHUMAN; PANCREATITIS; PROTOZOAL INFECTION; QT PROLONGATION; REVIEW; SIDE EFFECT; SKIN BIOPSY; T WAVE; THROMBOCYTOPENIA; TOXOPLASMA GONDII; TOXOPLASMOSIS; TRYPANOSOMA; TRYPANOSOMA CRUZI; TRYPANOSOMA RHODESIENSE; TRYPANOSOMIASIS;

AMEBIASIS; ANIMALS; ANTIPARASITIC AGENTS; DIAGNOSIS, DIFFERENTIAL; HUMANS; LEISHMANIASIS, CUTANEOUS; SKIN DISEASES, PARASITIC; TOXOPLASMOSIS; TRYPANOSOMIASIS;

EID: 10644273489     PISSN: 13960296     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1396-0296.2004.04054.x     Document Type: Review

References (7)

1. Parshad S, Grover PS, Sharma A, Verma DK, Sharma A. Primary cutaneous amoebiasis: case report with review of the literature. Int J Dermatol 2002 October. 41 (10): 676-680.
2. Herwaldt BL. Leishmaniasis. Lancet 1999 October 2: 354 (9185): 1191-1199.
3. Herwaldt BL, Berman JD. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg 1992 March: 46 (3): 296-306.
4. Uzun S, Uslular C, Yucel A, Acar MA, Ozpoyraz M, Memisoglu HR. Cutaneous leishmaniasis: evaluation of 3074 cases in the Cukurova region of Turkey. Br J Dermatol 1999 February: 140 (2): 347-350.
5. Hepburn NC. Cutaneous leishmaniasis: an overview. J Postgrad Med 2003 January-March: 49 (1): 50-54.
6. Arevalo I, Ward B, Miller R, et al. Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator. Clin Infect Dis 2001 December 1: 33 (11): 1847-1851. Available at http:// www.ncbi.nlm.nih.gov/entrez/query.fcgi, accessed October 23, 2001.
7. Jha TK, Sundar S, Thakur CP, et al. Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. N Engl J Med 1999 December 9: 341 (24): 1795-1800.